Equities

Dr Martens PLC

DOCS:LSE

Dr Martens PLC

Consumer DiscretionaryPersonal Goods
  • Price (GBX)85.25
  • Today's Change0.25 / 0.29%
  • Shares traded789.91k
  • 1 Year change-50.00%
  • Beta0.2954
Data delayed at least 20 minutes, as of May 20 2024 15:43 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Dr Martens PLC had net income fall -28.86% from 181.20m to 128.90m despite a 10.13% increase in revenues from 908.30m to 1.00bn. An increase in the selling, general and administrative costs as a percentage of sales from 34.77% to 37.30% was a component in the falling net income despite rising revenues.
Gross margin62.94%
Net profit margin10.56%
Operating margin15.47%
Return on assets10.27%
Return on equity29.07%
Return on investment12.99%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Dr Martens PLC fell by 70.50m. However, the company earned 77.30m from its operations for a Cash Flow Margin of 7.73%. In addition the company used 50.60m on investing activities and also paid 99.50m in financing cash flows.
Cash flow per share0.1718
Price/Cash flow per share4.75
Book value per share0.3678
Tangible book value per share0.0992
More ▼

Balance sheet in GBPView more

Dr Martens PLC has a Debt to Total Capital ratio of 59.30%, a lower figure than the previous year's 118.50%.
Current ratio2.44
Quick ratio0.8789
Total debt/total equity1.46
Total debt/total capital0.593
More ▼

Growth rates in GBP

Year on year, growth in dividends per share increased 6.18% while earnings per share excluding extraordinary items fell by -28.74%. The positive trend in dividend payments is noteworthy since only some companies in the Footwear industry pay a dividend.
Div yield(5 year avg)1.28%
Div growth rate (5 year)--
Payout ratio (TTM)56.40%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-41.64
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.